$RNTX
Rein Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$0.600
▼Pre-market-1.99%-$0.012Pre-market
Rein Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RNTX up today? It is at $0.600 (+0.00%), and our scanner flagged it 28 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RNTX spikes, and full due diligence on RNTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RNTX 28 times in the last 30 days. Create a free account to track $RNTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RNTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystHarnessing fibrosis, unleashing life Science Deck|Reported 10 µM LTI-03 is equivalent to an approximate dose of 1 mg in a dry powder inhaler. Phase 1b trial tested 5mg and 10mg, both of which were safe and well tolerated • TSLP and IL-11 were attenuated by LTI-03 and Nintedanib Day 4, from the latest SEC filing. Read it →Across every filing on file, supply equal to 134.5% of the tradeable float is in play - 134.5% more can still be issued.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
57,500,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $10.0M in size · Priced at $1/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Von Rickenbach Josef H Director | Bought (open market) | +5K | added 7.8% | 63K | $5K at $1.07 | May 27, 26 |
Von Rickenbach Josef H Director | Bought (open market) | +23K 0.03% of company | added 67% | 58K | $25K at $1.06 | May 26, 26 |
Von Rickenbach Josef H Director | Bought (open market) | +16K 0.02% of company | added 85% | 35K | $17K at $1.05 | May 22, 26 |
Von Rickenbach Josef H Director | Bought (open market) | +3K | added 22% | 19K | $4K at $1.04 | May 21, 26 |
Windsor James Brian Officer | Bought (open market) | +25K 0.03% of company | added 100% | 27K | $25K at $1.00 | Apr 30, 26 |
Voss Capital, Lp Beneficial Owner (10%) | Bought (open market) | +104K 0.1% of company | added 7.9% | 1.43M | $127K at $1.22 | Nov 14, 25 |
Voss Capital, Lp Beneficial Owner (10%) | Bought (open market) | +178K 0.2% of company | added 16% | 1.32M | $248K at $1.39 | Oct 28, 25 |
Voss Capital, Lp Beneficial Owner (10%) | Bought (open market) | +97K 0.1% of company | added 13% | 822K | $134K at $1.37 | Oct 27, 25 |
Voss Capital, Lp Beneficial Owner (10%) | Bought (open market) | +30K 0.03% of company | added 4.3% | 730K | $42K at $1.39 | Oct 24, 25 |
Windsor James Brian Officer | Bought (open market) | +400 | n/a | 225 | $896 at $2.24 | Dec 5, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on RNTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RNTX last traded at $0.600, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Rein Therapeutics, Inc. Common Stock (RNTX) is next expected to report earnings on Friday, November 13, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RNTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RNTX 28 times in the last 30 days.
RNTX (Rein Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $53M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RNTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RNTX discussion
Sign in to ask a question or join the discussion.